Castro NG, Albuquerque EX (1995). Alpha-bungarotoxin-sensitive
hippocampal nicotinic receptor channel has a high calcium
permeability. Biophys J 68: 516–524.
Ceresoli-Borroni G, Guidetti P, Schwarcz R (1999a). Acute and
chronic changes in kynurenate formation following an intrastriatal quinolinate injection in rats. J Neural Transm 106:
229–242.
Ceresoli-Borroni G, Wu HQ, Guidetti P, Rassoulpour A, Roberts
RC, Schwarcz R (1999b). Chronic haloperidol administration
decreases kynurenic acid levels in rat brain. Soc Neurosci Abstr
25: 727.8.
Court JA, Lloyd S, Thomas N, Piggott MA, Marshall EF, Morris CM
et al (1998). Dopamine and nicotinic receptor binding and the
levels of dopamine and homovanillic acid in human brain
related to tobacco use. Neuroscience 87: 63–78.
Coyle JT, Tsai G (2004). NMDA receptor function, neuroplasticity,
and the pathophysiology of schizophrenia. Int Rev Neurobiol 59:
491–515.
Cozzi A, Carpenedo R, Moroni F (1999). Kynurenine hydroxylase
inhibitors reduce ischemic brain damage: studies with
(m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4- (nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in
models of focal or global brain ischemia. J Cereb Blood Flow
Metab 19: 771–777.
Erhardt S, Blennow K, Nordin C, Skogh E, Lindstro ̈m LH, Engberg
G (2001a). Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia. Neurosci Lett 313:
96–98.
Erhardt S, Hajos M, Lindberg A, Engberg G (2000). Nicotineinduced excitation of locus coeruleus neurons is blocked
by elevated levels of endogenous kynurenic acid. Synapse 37:
104–108.
Erhardt S, O ̈ berg H, Engberg G (2001b). Pharmacologically
elevated levels of endogenous kynurenic acid prevent nicotineinduced activation of nigral dopamine neurons. NaunynSchmiedeberg's Arch Pharmacol 363: 21–27.
Erhardt S, Schwieler L, Engberg G (2002). Excitatory and
inhibitory responses of dopamine neurons in the ventral
tegmental area to nicotine. Synapse 43: 227–237.
Foster AC, Vezzani A, French ED, Schwarcz R (1984). Kynurenic
acid blocks neurotoxicity and seizures induced in rats by the
related brain metabolite quinolinic acid. Neurosci Lett 48:
273–278.
Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A,
Davis A et al (1997). Linkage of a neurophysiological deficit in
schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci
USA 94: 587–592.
Freedman R, Hall M, Adler LE, Leonard S (1995). Evidence in
postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry 38:
22–33.
George TP, Sernyak MJ, Ziedonis DM, Woods SW (1995). Effects of
clozapine on smoking in chronic schizophrenic outpatients.
J Clin Psychiatry 56: 344–346.
Gramsbergen JBP, Hodgkins PS, Rassoulpour A, Turski WA,
Guidetti P, Schwarcz R (1997). Brain-specific modulation of
kynurenic acid synthesis in the rat. J Neurochem 69: 290–298.
Gray R, Rajan AS, Radcliffe KA, Yakehiro M, Dani JA (1996).
Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383: 713–716.
Guan ZZ, Zhang X, Blennow K, Nordberg A (1999). Decreased
protein level of nicotinic receptor alpha7 subunit in the frontal
cortex from schizophrenic brain. Neuroreport 10: 1779–1782.
Guidetti P, Okuno E., Schwarcz R (1997). Characterization of rat
brain kynurenine amino-transferases I and II. J Neurosci Res 50:
457–465.
Guillemin GJ, Kerr SJ, Smythe GA, Smith DG, Kapoor V, Armati PJ
et al (2001). Kynurenine pathway metabolism in human
